Skip to main content

Market Overview

Corvus Pharma (NASDAQ: CRVS)

2.84 +0.03 (1.07%)

Earnings

QuarterPriorEstimateActualSurprise
Q1 2022
After-Hours
EPS:
REV:
-0.34
0



Q4 2021
Pre-Market
EPS:
REV:
-0.34
0



Q3 2021
After-Hours
EPS:
REV:
-0.33
0



Q2 2021
After-Hours
EPS:
REV:




Q1 2021
After-Hours
EPS:
REV:
-0.44
0
-0.31
-0.34
0
-9.68%
Q4 2020
Pre-Market
EPS:
REV:
-0.38
0
-0.32
-0.34
0
-6.25%
Q3 2020
After-Hours
EPS:
REV:
-0.37
0
-0.24
-0.33
0
-37.5%
Q2 2020
After-Hours
EPS:
REV:
-0.44
0
-0.28
-0.36
0
-28.57%
Q1 2020
After-Hours
EPS:
REV:
-0.40
0
-0.40
-0.44
0
-10%
Q4 2019
After-Hours
EPS:
REV:
-0.36
-0.33
-0.38
0
-15.15%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!